Creative Planning
LEGN icon

Creative Planning’s Legend Biotech LEGN Stock Holding History

Creative Planning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
79,946
+24,929
+45% +$672K ﹤0.01% 1967
2026
Q1 		$995K Buy
55,017
+37,136
+208% +$708K ﹤0.01% 2461
2025
Q4 		$389K Sell
17,881
-27,426
-61% -$786K ﹤0.01% 3047
2025
Q3 		$1.48M Buy
45,307
+1,999
+5% +$73.8K ﹤0.01% 1774
2025
Q2 		$1.54M Buy
43,308
+30,354
+234% +$984K ﹤0.01% 1523
2025
Q1 		$440K Sell
12,954
-2,986
-19% -$107K ﹤0.01% 2404
2024
Q4 		$519K Buy
+15,940
New +$660K ﹤0.01% 2185

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Creative Planning's LEGN Position: Q2 2026 in Review

Creative Planning increased its Legend Biotech (LEGN) stake by 45% in Q2 2026, buying an estimated $672K and bringing the position to 79,946 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Creative Planning first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Creative Planning held 79,946 shares of Legend Biotech worth $2.31M as of Q2 2026.
  • Creative Planning bought 24,929 Legend Biotech shares in Q2 2026, an estimated $672K.
  • Legend Biotech made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1967 holding.
  • Creative Planning first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.